Baillie Gifford & Co
TDOC icon

Baillie Gifford & Co’s Teladoc Health TDOC Stock Holding History

Baillie Gifford & Co’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,589,851
Closed -$34.3M – 300
2023
Q4 		$34.3M Sell
1,589,851
-170,057
-10% -$3.14M 0.03% 171
2023
Q3 		$32.7M Sell
1,759,908
-16,670
-0.9% -$389K 0.03% 165
2023
Q2 		$45M Sell
1,776,578
-3,050,303
-63% -$76.8M 0.04% 155
2023
Q1 		$125M Buy
4,826,881
+79,670
+2% +$2.13M 0.11% 112
2022
Q4 		$112M Sell
4,747,211
-497,789
-9% -$13.4M 0.12% 108
2022
Q3 		$133M Sell
5,245,000
-2,494,623
-32% -$87.5M 0.14% 103
2022
Q2 		$257M Sell
7,739,623
-2,988,476
-28% -$127M 0.26% 80
2022
Q1 		$774M Sell
10,728,099
-148,964
-1% -$10.7M 0.54% 50
2021
Q4 		$999M Buy
10,877,063
+2,071,756
+24% +$248M 0.55% 52
2021
Q3 		$1.12B Buy
8,805,307
+388,063
+5% +$56.5M 0.58% 46
2021
Q2 		$1.4B Buy
8,417,244
+478,165
+6% +$77.5M 0.68% 39
2021
Q1 		$1.44B Buy
7,939,079
+700,412
+10% +$162M 0.81% 32
2020
Q4 		$1.45B Buy
7,238,667
+996,628
+16% +$203M 0.81% 30
2020
Q3 		$1.37B Buy
6,242,039
+275,608
+5% +$58.4M 0.94% 27
2020
Q2 		$1.14B Buy
5,966,431
+192,429
+3% +$33.7M 0.87% 27
2020
Q1 		$895M Buy
5,774,002
+41,779
+0.7% +$4.86M 0.97% 27
2019
Q4 		$480M Buy
5,732,223
+1,974,923
+53% +$150M 0.46% 53
2019
Q3 		$254M Buy
3,757,300
+2,873,793
+325% +$189M 0.29% 76
2019
Q2 		$58.7M Sell
883,507
-3,861
-0.4% -$225K 0.06% 119
2019
Q1 		$49.3M Buy
887,368
+147,326
+20% +$8.99M 0.05% 121
2018
Q4 		$36.7M Buy
740,042
+40,215
+6% +$2.46M 0.05% 126
2018
Q3 		$60.4M Buy
699,827
+86,183
+14% +$6.14M 0.07% 114
2018
Q2 		$35.6M Buy
613,644
+82,783
+16% +$4.04M 0.04% 126
2018
Q1 		$21.4M Buy
530,861
+182,936
+53% +$6.91M 0.03% 134
2017
Q4 		$12.1M Buy
347,925
+41,913
+14% +$1.39M 0.02% 161
2017
Q3 		$10.1M Buy
306,012
+21,012
+7% +$689K 0.01% 161
2017
Q2 		$9.89M Buy
285,000
+82,000
+40% +$2.39M 0.01% 162
2017
Q1 		$5.08M Buy
+203,000
New +$4.22M 0.01% 172

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Baillie Gifford & Co's TDOC Position: Q1 2024 in Review

Baillie Gifford & Co sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 1,589,851 shares — an estimated $34.3M sold.

Baillie Gifford & Co first reported a position in TDOC in Q1 2017 and held it in 28 quarters. The position peaked at $1.45B in Q4 2020. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Baillie Gifford & Co reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Baillie Gifford & Co sold 1,589,851 Teladoc Health shares in Q1 2024, an estimated $34.3M.
  • Baillie Gifford & Co first reported a position in Teladoc Health in Q1 2017 and held it in 28 quarters.
  • Baillie Gifford & Co's Teladoc Health position peaked at $1.45B in Q4 2020.
  • 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Baillie Gifford & Co's 13F filing for Q1 2024, filed 1 May 2024.